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| INTRODUC TI ON
Postmenopausal osteoporosis (PMOP) is a chronic systematic disorder of bone metabolism, which is characterized by bone loss, microstructure deterioration, and prone to fragility fracture. 1, 2 Osteoporotic fractures, also known as brittle fractures, are different from fractures that result from violent collisions or unexpected blows; it refers to fractures that occur without trauma or minor trauma. 3 With the aging of the population rapidly increasing, PMOP is becoming prevalent in postmenopausal women in recent years, causing a serious social health problem and heavy economical burdens. 4, 5 To date, early detection of PMOP and intervention with protective measures have been the most effective healthcare strategies in PMOP management. Traditional diagnostic approach for PMOP is largely based on the dual-energy X-ray absorptiometry (DEXA) and assessed by bone mineral density (BMD). 2 However, a great number of postmenopausal women are unaware of PMOP and tend not to receive DEXA scanning until some adverse incidents owing to osteoporosis occur, such as bone pain or even bone fracture. Therefore, it is urgent to identify easy and efficient biomarkers to early recognize PMOP among postmenopausal women. 6 It has been well established that PMOP pathogenesis is closely related to body immune dysfunction and systematic inflammation activation. 7, 8 Because women would lose the protection of endogenous estrogen after menopause, a mass of inflammatory cytokines increasingly accumulates, such as tumor necrosis factor-alpha, interleukin (IL)-6, IL-12, and IL-17. These inflammatory cytokines could mediate oxidative stress injury, provoke osteoclast, and enhance bone absorbability, thus gradually leading to skeletal remodeling and PMOP. 9 Therefore, it is reasonable to resort to systematic inflammatory biomarkers to early recognize PMOP. For instance, some emerging studies suggested blood neutrophil-to-lymphocyte ratio (NLR). As a simple peripheral blood index which could reflect the systemic inflammatory level, NLR can well discriminate PMOP among postmenopausal women, even being superior to C reaction protein. 10, 11 However, to date, scarce study further explored if there are more optimal biomarkers other than NLR in blood routine examination for diagnosing PMOP, and if there are any blood biomarkers could predict fracture risk among PMOP patients.
Given that blood routine examination is easily available, economical and contains abundant useful parameters, it should not be underutilized in PMOP diagnosis and management, which deserves to be further explored. Thus in this study, we established a multicentric cohort consisting of postmenopausal women provided with high-quality data. We mainly aimed to (a) identify more optimal and novel blood biomarkers besides NLR for diagnosing PMOP among postmenopausal women and (b) first explore biomarkers based on blood routine examination for predicting osteoporotic fracture among Chinese PMOP patients.
| MATERIAL S AND ME THODS

| Study participants
This study was conducted with a prospective cohort design and en- Hospital of Traditional Chinese Medicine, respectively. There were no significant differences regarding age, menopause duration, body mass index (BMI), and BMD between the participants from the two institutions. This study was approved by the Ethics Committees of the institutions. All participants were fully informed of this study and given the written consent for participation.
| Clinical examinations and follow-up
All participants enrolled in this study underwent the DEXA scanning (HOLOGIC DISCOVERY A). The BMD values of the lumbar spine 2-4 and neck of femur were evaluated. BMD values were presented as mineral amount (g) per scanned area (cm 2 ) and then transformed into T-scores based on corresponding coefficients. According to the PMOP diagnosis criteria defined by the World Health Organization, 12 the participants with a T-score ≤−2.5 were divided into the PMOP patients, while the participants with a T-score ≥−1 were divided into the normal group, and the others with −2.5 ≤T-score ≤−1 were divided into the osteopenia group.
In order to obtain a comprehensive blood routine examination, venous blood samples about 6 mL were collected from all participants after overnight fasting. Then, the blood samples were soon 
| Statistical analysis
All statistical analyses and graphics were conducted in SPSS 22.0 and GraphPad Prism 7.0. Continuous data were expressed as mean ± standard deviation (SD) and examined by Student's t test.
Categorical data were expressed as absolute number with percentage and examined by the chi-square test. Univariate logistic analysis was employed to preliminarily screen the potential risk factors for PMOP. Factors with a P value less than .05 in the univariate analysis were sent into a forward stepwise multivariate logistic analysis to identify independent risk factors for PMOP. Odds ratio (OR) or hazard ratio (HR) with 95% confidence interval (CI) was used for measuring the strength of the association. Kaplan-Meier curve was depicted to explore the association of blood markers with bone fracture. The Cox proportional hazard regression analysis was used to identify the independent risk factors for fracture. All P values were two-sided, and P < .05 was considered statistically significant.
| RE SULTS
| Participants' baseline characteristics
The baseline characteristics of the study participants were presented in 
| Risk factors for PMOP patients
Univariate analyses were conducted to identify the parameters associated with PMOP diagnosis, and the results were presented in 
| Risk factors for osteoporotic fracture in PMOP patients
The median follow-up time was 38.8 (31.7-43.4) months. During this period, 15 PMOP patients happened to osteoporotic fracture, with an incidence rate of 16.30% (15/92). In the 77 patients with censored survival data, 12 patients were censored because of loss of contact or withdraw, 65 patients were censored because the outcome event did not occur until the end of the follow-up. As displayed in Figure 1 , TA B L E 3 Multivariate logistical regression analysis of risk factors for PMOP among postmenopausal women PMOP patients with age ≥60 years significantly tend to have osteoporotic fracture than those with age <60 years (P < .05; Figure 1A ).
PMOP patients with duration of menopause ≥12 years were also more likely to occur fracture (P < .05) ( Figure 1B) . High BMI ≥ 23 kg/ m 2 can play a protective effect on PMOP patients against fracture risk ( Figure 1C) . Although lower albumin level and higher NLR level seemed to increase the risk of fracture, the differences were not adequately achieve statistical significance (both P > .05; Figure 1D ,E).
SII displayed an excellent ability to discriminate high fracture risk patients or low fracture risk patients (P < .05; Figure 1H ). The other blood routine biomarkers, such as PDW, MCH, MCHC, and RDW, were shown to have no significant differences regarding fracture risks (all P > .05; Figure 1I -L, respectively).
In the subsequent hazard analysis, the HR of age ≥60 years for osteoporotic fracture was 3.65 (95% CI = 1.282-10.41). The HR of menopause duration ≥12 years for osteoporotic fracture was 2.88 (95% CI = 1.014-8.188). The HR of SII ≥ 834.89 for osteoporotic fracture was 3.66 (95% CI = 1.249-10.71), which exerted a significant risk predictive role for osteoporotic fracture in PMOP patients. Over the past decade, increasing studies have reported that many blood routine examination-derived biomarkers, such as NLR, PLR, and LMR, whose levels could be closely related to systemic inflammation and immune response status. 18 These biomarkers are proved to be well associated with various infectious diseases, oncological diseases and autoimmune diseases. [19] [20] [21] In recent years, following NLR, PLR, and LMR, SII has been discovered as an emerging indicator for these diseases and shed great predictive and diagnostic potential. 22 However, to date, whether SII could also help Although the novel findings as mentioned above, there were inevitably some limitations in our study. First, although we enrolled a great number of postmenopausal women as the participants, the number of our target population, namely PMOP patients, was still not abundant. The small sample size of our target population may restrict some further deep and meaningful subgroup analysis. Second, the follow-up time in our study seemed to be not adequately long to observe the outcome event of osteoporotic fracture incidence. Only a few PMOP patients occurred fracture until the endpoint, and this might lead to some fluctuation of the estimated HR values. Therefore, in the future, more PMOP patients should be enrolled and long followed in order to yield more meaningful and insightful findings. Third, PMOP is a systemic disease involving in multiple body disorders. Currently, we have adequately explored the inflammatory signs. However, there must be some other aberrant blood routine signs reflecting the disease.
| D ISCUSS I ON
Therefore, in the future, it is attractive and valuable to investigate more markers such as the blood lipid markers and blood coagulation markers in PMOP.
In summary, the present study newly identified that higher SII acts as a significant risk predictor for PMOP diagnosis among postmenopausal women. More than that, SII could also well discriminate the osteoporotic fracture risk in PMOP patients. Because SII is an easy and economical blood routine examination-derived biomarker, in the future clinical practice, it may play an important role in PMOP screening and prevention. 
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